318 related articles for article (PubMed ID: 26014930)
1. In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis.
Mario DN; Guarro J; Santurio JM; Alves SH; Capilla J
Antimicrob Agents Chemother; 2015 Aug; 59(8):5018-21. PubMed ID: 26014930
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis.
Ishida K; de Castro RA; Borba Dos Santos LP; Quintella LP; Lopes-Bezerra LM; Rozental S
Med Mycol; 2015 Jan; 53(1):34-41. PubMed ID: 25306202
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of posaconazole in murine experimental sporotrichosis.
Fernández-Silva F; Capilla J; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2012 May; 56(5):2273-7. PubMed ID: 22330929
[TBL] [Abstract][Full Text] [Related]
4. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
Fernández-Silva F; Capilla J; Mayayo E; Guarro J
Mycoses; 2014 Feb; 57(2):121-4. PubMed ID: 23879298
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis.
Ishida K; Castro RA; Torrado JJ; Serrano DR; Borba-Santos LP; Quintella LP; de Souza W; Rozental S; Lopes-Bezerra LM
Med Mycol; 2018 Apr; 56(3):288-296. PubMed ID: 28575449
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Han HS; Kano R; Chen C; Noli C
Vet Dermatol; 2017 Feb; 28(1):156-e32. PubMed ID: 28133872
[TBL] [Abstract][Full Text] [Related]
7. Disseminated sporotrichosis in a patient with hairy cell leukemia treated with amphotericin B and posaconazole.
Bunce PE; Yang L; Chun S; Zhang SX; Trinkaus MA; Matukas LM
Med Mycol; 2012 Feb; 50(2):197-201. PubMed ID: 21612561
[TBL] [Abstract][Full Text] [Related]
8. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing.
Kohler LM; Hamdan JS; Ferrari TC
Diagn Microbiol Infect Dis; 2007 May; 58(1):117-20. PubMed ID: 17498572
[TBL] [Abstract][Full Text] [Related]
10. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.
Batista-Duharte A; Lastre M; Romeu B; Portuondo DL; Téllez-Martínez D; Manente FA; Pérez O; Carlos IZ
Int Immunopharmacol; 2016 Nov; 40():277-287. PubMed ID: 27639705
[TBL] [Abstract][Full Text] [Related]
11. Sporotrichosis.
Vásquez-del-Mercado E; Arenas R; Padilla-Desgarenes C
Clin Dermatol; 2012; 30(4):437-43. PubMed ID: 22682194
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of four antifungal agents in experimental murine sporotrichosis.
Kan VL; Bennett JE
Antimicrob Agents Chemother; 1988 Nov; 32(11):1619-23. PubMed ID: 2855294
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
[TBL] [Abstract][Full Text] [Related]
15. Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B.
Mario DA; Santos RC; Denardi LB; Vaucher Rde A; Santurio JM; Alves SH
Rev Iberoam Micol; 2016; 33(1):21-5. PubMed ID: 26194334
[TBL] [Abstract][Full Text] [Related]
16. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
17. Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.
Baker JH; Goodpasture HC; Kuhns HR; Rinaldi MG
Arch Pathol Lab Med; 1989 Nov; 113(11):1279-81. PubMed ID: 2554844
[TBL] [Abstract][Full Text] [Related]
18. Disseminated cutaneous sporotrichosis presenting as a necrotic facial mass: Case and review.
He Y; Ma C; Fung M; Fitzmaurice S
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469701
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Córdoba S; Isla G; Szusz W; Vivot W; Hevia A; Davel G; Canteros CE
Mycoses; 2018 Jul; 61(7):441-448. PubMed ID: 29500853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
